News Conference News TCT 2025 Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions Todd Neale October 26, 2025
News Conference News SCCT 2024 Should Coronary Calcium Always Be Noted on Noncardiac CT Reports? Todd Neale July 24, 2024
News Conference News ACC 2023 Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III Shelley Wood March 04, 2023
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Conference News ESC 2019 New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD Shelley Wood August 31, 2019
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Conference News EAS 2017 Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive Yael L. Maxwell May 01, 2017
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016
News Conference News EuroPCR 2016 Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events Shelley Wood May 18, 2016
News Conference News ACC 2016 Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH Michael O'Riordan April 03, 2016
News Conference News ESC 2013 AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction Caitlin E. Cox September 04, 2013
News Conference News ESC 2012 Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis Caitlin E. Cox August 29, 2012